HomeNDC LookupRxCUI directory › RxCUI 318146

Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution — RxCUI 318146

RxNorm drug concept · Semantic clinical drug
RxCUI 318146 Semantic clinical drug · SCD ● Current RxNorm concept 17 FDA products 19 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI318146
Official nameFructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG per 5 ML Oral Solution; dextrose 1.87 GM / fructose 1.87 GM / phosphoric acid 21.5 MG in 5 mL Oral Solution
FDA products mapped17
Package NDCs mapped19
Reported Medicaid activity (SDUD)18 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextrose: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dextrose is essentially glucose — sugar — given directly into a vein. In an emergency, it's used to quickly raise dangerously low blood sugar, which can happen with too much insuli...
  • Specific formulations — Infant Dextrose (25%) and Dextrose (25% injection) — are FDA-approved to treat low blood sugar in newborns and infants up to 2 years old. That said, prematu...
  • Is dextrose safe for my baby or newborn?
  • The most common issues are high blood sugar, vein irritation or clotting at the IV site, low sodium in the blood, and infection. More serious — but less common — reactions include...
📖 Read our full Dextrose guide →

🕸️ Concept Web — How Fructose 374 MG/ML / glucose 374 MG/ML / phospho... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fructose 374 MG/ML / glucose 374 MG/ML / phosphoric acid 4.3 MG/ML Oral Solution RxCUI 318146

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Fructose 4570
    • Glucose 4850
    • Phosphoric acid 8259
    • Fructose / glucose / phosphoric acid 689313
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Emetrol 92588
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fructose / glucose / phosphoric acid Oral Solution 377010
    • Fructose / glucose / phosphoric acid Oral Liquid Product 1162688
    • Fructose / glucose / phosphoric acid Oral Product 1162689
    • Fructose / glucose / phosphoric acid Oral Solution [Emetrol] 364369
    • Emetrol Oral Liquid Product 1175311
    • Emetrol Oral Product 1175312
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fructose 374 MG/ML SCDC · 336945
  • Glucose 374 MG/ML SCDC · 336547
  • Phosphoric acid 4.3 MG/ML SCDC · 336548
  • Fructose / glucose / phosphoric acid Oral Solution SCDF · 377010
  • Fructose / glucose / phosphoric acid Oral Liquid Product SCDG · 1162688
  • Fructose / glucose / phosphoric acid Oral Product SCDG · 1162689

Brand-Name Concepts

📦 FDA Products & Package NDCs

17 products · 19 package NDCs
19 package NDCs map to RxCUI 318146 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-7080-04 1 BOTTLE in 1 CARTON (0363-7080-04) / 118 mL in 1 BOTTLE Walgreen Anti Nausea Cherry Flavor WALGREENS CO. 2023-10-16
00363-7081-04 1 BOTTLE in 1 CARTON (0363-7081-04) / 118 mL in 1 BOTTLE WALGREEN CHILDREN ANTI NAUSEA WALGREENS CO. 2025-12-29
00536-1302-97 1 BOTTLE in 1 CARTON (0536-1302-97) / 118 mL in 1 BOTTLE Anti Nausea RUGBY LABORATORIES 2020-09-09
30142-0708-04 1 BOTTLE in 1 CARTON (30142-708-04) / 118 mL in 1 BOTTLE Kroger Anti Nausea Cherry Flavor KROGER COMPANY 2020-03-31
36800-0708-04 1 BOTTLE in 1 CARTON (36800-708-04) / 118 mL in 1 BOTTLE Anti Nausea Liquid TOPCO ASSOCIATES LLC 2018-05-14
37808-0883-04 1 BOTTLE in 1 CARTON (37808-883-04) / 118 mL in 1 BOTTLE HEB Anti Nausea HEB 2020-04-20
41250-0495-04 1 BOTTLE in 1 CARTON (41250-495-04) / 118 mL in 1 BOTTLE Meijer Anti Nausea MEIJER DISTRIBUTION, INC. 2020-06-29
46122-0729-26 1 BOTTLE in 1 CARTON (46122-729-26) / 118 mL in 1 BOTTLE Good Neighbor Anti Nausea Cherry Flavor AMERISOURCE BERGEN 2023-05-01
53943-0708-04 1 BOTTLE in 1 CARTON (53943-708-04) / 118 mL in 1 BOTTLE Discount Drug Mart nausea control Cherry Flavor DISCOUNT DRUG MART 2019-03-28
63868-0704-04 1 BOTTLE in 1 CARTON (63868-704-04) / 118 mL in 1 BOTTLE Anti Nausea Liquid Cherry Flavor QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) 2019-04-16
63941-0708-04 1 BOTTLE in 1 CARTON (63941-708-04) / 118 mL in 1 BOTTLE Best Choice Anti Nausea Cherry Flavor BEST CHOICE (VALU MERCHANDISERS COMPANY) 2019-04-16
65197-0201-04 1 BOTTLE in 1 CARTON (65197-201-04) / 118 mL in 1 BOTTLE Emetrol Cherry WellSpring Pharmaceutical Corporation 2009-06-24
65197-0201-06 133 mL in 1 BOTTLE (65197-201-06) Emetrol Cherry WellSpring Pharmaceutical Corporation 2018-11-01
65197-0201-12 354 mL in 1 BOTTLE (65197-201-12) Emetrol Cherry WellSpring Pharmaceutical Corporation 2025-06-15
65197-0202-14 1 BOTTLE in 1 CARTON (65197-202-14) / 118 mL in 1 BOTTLE Emetrol Children Mixed Berry WellSpring Pharmaceutical Corporation 2023-06-01
68016-0807-04 1 BOTTLE in 1 CARTON (68016-807-04) / 118 mL in 1 BOTTLE Premier Value Nausea Control Cherry Flavor PHARMACY VALUE ALLIANCE, LLC 2019-04-16
69842-0708-04 1 BOTTLE in 1 CARTON (69842-708-04) / 118 mL in 1 BOTTLE CVS Anti Nausea Cherry Flavor CVS PHARMACY 2020-03-31
70000-0052-01 1 BOTTLE in 1 CARTON (70000-0052-1) / 118 mL in 1 BOTTLE Anti Nausea Cardinal Health 2020-07-29
83324-0217-04 1 BOTTLE in 1 CARTON (83324-217-04) / 118 mL in 1 BOTTLE QUALITY CHOICE Anti-Nausea QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) 2024-10-08
Observed labelers: WellSpring Pharmaceutical Corporation (4) · QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) (2) · WALGREENS CO. (2) · AMERISOURCE BERGEN (1) · BEST CHOICE (VALU MERCHANDISERS COMPANY) (1) · Cardinal Health (1) · +8 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.